About Mepfarma India Private Limited
Data last updated:
Mepfarma India Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 September 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2012PTC034097. Its GSTIN is 06AAICM2315D1ZY (Haryana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors Vinay Chadha (Managing Director) and Ramandeep Garg.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Scf 270 Ground Floor Motor Market Manimajra, Chandigarh, India – 160101.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.18 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹7.86 Lakh (net margin 2.5%) and EBITDA of ₹18.34 Lakh (EBITDA margin 5.8%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years and 3% over five years.
As per MCA filings, the company has open charges of ₹1.04 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mepfarmaindia.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressScf 270 Ground Floor Motor Market Manimajra, Chandigarh, India – 160101
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Mepfarma India Private Limited
The main business activity of Mepfarma India is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Mepfarma India Private Limited
Mepfarma India Private Limited is audited by VIKAS SANJIV & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| VIKAS SANJIV & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Mepfarma India Private Limited
Mepfarma India has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vinay Chadha Also directs: Ultra Biolabs Private Limited, Logimed Pharma Private Limited | Managing Director | 20 Sep 2012 | 14 Years 0 Months | Current |
| Ramandeep Garg | Director | 20 Sep 2012 | 14 Years 0 Months | Current |
Financials of Mepfarma India Private Limited FY 2025 filings available
Mepfarma India Private Limited reported revenue of ₹3.18 Cr (down 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Mepfarma India Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 6% fall in the latest year. EBITDA fell 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Mepfarma India Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹18.34 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹7.86 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Mepfarma India Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Mepfarma India are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Mepfarma India Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Mepfarma India Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jul 2019 | Others | ₹1.04 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Mepfarma India Private Limited
Employment history and EPFO contributions of people linked to Mepfarma India.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Mepfarma India Private Limited
Mepfarma India has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAICM2315D1ZY | Haryana | Active | 12 Sep 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Mepfarma India Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Mepfarma India Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Mepfarma India Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Mepfarma India Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Mepfarma India Private Limited
Frequently Asked Questions about Mepfarma India Private Limited
Mepfarma India is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 September 2012 (14+ years old) and is registered under CIN U24232CH2012PTC034097.
Mepfarma India reported revenue of ₹3.18 Cr for FY 2025 (down 6% YoY).
Mepfarma India has 2 current directors:
- Vinay Chadha - Managing Director
- Ramandeep Garg - Director
Mepfarma India reported a net profit of ₹7.86 Lakh (net margin 2.5%) and EBITDA of ₹18.34 Lakh (EBITDA margin 5.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Mepfarma India is -5% over three years and -3% over five years. In the latest year (FY 2025) revenue fell 6%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Mepfarma India is 06AAICM2315D1ZY, registered in Haryana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Mepfarma India is U24232CH2012PTC034097. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mepfarma India was incorporated on 20 September 2012, making it 14+ years old. It is registered with the Registrar of Companies, Chandigarh.
Mepfarma India can be reached through the website mepfarmaindia.com. Its registered office is in Chandigarh, India.